Newsletter

Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria market expects the entry of novel treatment options to address a life-threatening disease of the blood.
Paroxysmal Nocturnal Hemoglobinuria Newsletter

More Whitepapers / Newsletters

Exocrine Pancreatic Insufficiency
Exocrine Pancreatic Insufficie...

A degenerative disease, Exocrine Pancreatic Insufficiency (EPI), is a consequence of insufficient production and secretion of pancreatic digestive enzymes, which leads to maldigestion in the duodenum....

Car-T Cell Therapy: A Journey From Challenges To Opportunities
Car-T Cell Therapy: A Journey...

With its innovative approach, chimeric antigen receptor T cell therapy created a new dawn in the age of cancer. Immunotherapy can be taken as a very powerful tool that can alter the immune system's pi...

Cancer In The United States(Vol 1, Issue 2)
Cancer In The United States(Vo...

US Cancer Statistics show that more than half a million suffer from this disease, which is the second leading cause of death in the country. The newsletter Cancer in the US substantiates the increasin...

Hereditary ATTR (HATTR) Amyloidosis
Hereditary ATTR (HATTR) Amyloi...

Transthyretin Amyloidosis (ATTR) is a progressive build-up of abnormal deposits of amyloid protein in the body's organs and tissues. Hereditary ATTR (hATTR) amyloidosis is the most common form of ATTR...

The Ophthalmic Drug Delivery Therapeutics For Retinal Disorders Whitepaper
The Ophthalmic Drug Delivery T...

Delivery of therapeutics to the human eye is among the most interesting endeavours a formulator can take on, but also one of the most challenging. The anatomy and chemical make-up of the eye make it h...